CytoSorbents nabs new U.S. gov contract for new blood filter
Jul. 31, 2020 7:35 AMCytosorbents Corporation (CTSO)By: Douglas W. House, SA News Editor
A medical research unit of the U.S. Department of Defense has awarded a contract valued at ~$4.4M to CytoSorbents (NASDAQ:CTSO) to support the completion of preclinical development of its HemoDefend-BGA plasma and whole blood absorber, designed to enable "universal plasma" and to improve the safety of whole blood transfusions via the removal of anti-A and anti-B antibodies from the blood.